If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.



Arkema Makes $2.2 Billion Offer For Glue Maker Bostik

Acquisition: Deal would continue French firm’s shift toward specialties

by Alex Scott
September 25, 2014 | A version of this story appeared in Volume 92, Issue 39

The French chemical maker Arkema has offered to buy the adhesives producer Bostik from Total for $2.2 billion. Total, a French oil company that has been gradually exiting the chemical business, has granted Arkema an exclusivity period to pursue the offer.

Bostik is the world’s third-largest adhesives maker after Henkel and H.B. Fuller, according to an Arkema presentation released after the deal was announced. It has 4,900 employees and annual sales of $2 billion from adhesives sold in industrial, construction, and consumer markets.

The proposed purchase is a “major milestone” in Arkema’s strategy, under way since the firm was formed in 2006 as a spin-off from Total, to transform itself from a producer of commodity chemicals to one making specialties, Arkema CEO Thierry Le Hénaff says. The acquisition would increase Arkema’s annual sales to $10 billion and its employee headcount to 19,000. Profit margins and sales growth would also rise, Le Hénaff adds.

Jürgen Wegner, a vice president at the consulting firm ChemQuest, doesn’t anticipate regulatory scrutiny of the deal, but he doesn’t see a perfect fit either. “Since Arkema has little business with adhesive and sealant formulators, I do not see any sizable conflict of interest,” he says. “On the other hand, Arkema has little to no experience with Bostik’s technology and market penetration; thus synergies between the two businesses will be rather limited.”

As a result of the proposed acquisition, Arkema now plans to divest noncore businesses with combined sales of just under $650 million per year, a hike on its previous plan.


This article has been sent to the following recipient:

Chemistry matters. Join us to get the news you need.